XML 211 R2.htm IDEA: XBRL DOCUMENT v3.24.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current assets:                    
Cash and cash equivalents $ 37,061     $ 51,775       $ 63,741    
Marketable securities 4,975     48,983       81,658    
Accounts receivable, net - related party 435     2,765       3,260    
Inventory, net 625     2,821       2,383    
Income tax receivable       697       697    
Other receivables 934     555       496    
Prepaid expenses 2,382     8,154       16,267    
Restricted cash 1,500     408       408    
Total current assets 47,912     116,158       168,910    
Operating lease right-of-use assets       4,864       1,551    
Marketable securities, non-current               11,350    
Property and equipment, net 3,417     3,322       426    
Restricted cash, non-current       1,500            
Total assets 51,329     125,844       182,237    
Current liabilities:                    
Accounts payable and accrued expenses 6,622     25,592       21,540    
Operating lease liability, current 3,417             1,918    
Total current liabilities 10,039     25,592       23,458    
Liability related to sales of future royalties and milestones, net 40,583     37,079            
Operating lease liability, non-current       6,088            
Total liabilities 50,622     68,759       23,458    
Commitments and contingencies (Note 17)              
Stockholders' equity:                    
Preferred stock; $0.001 par value; 5,000,000 shares authorized at September 30, 2024 and December 31, 2023, zero shares issued and outstanding at September 30, 2024 and December 31, 2023              
Common stock; $0.001 par value; 200,000,000 shares and 100,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively, 54,846,639 shares and 54,480,704 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 5     5       4    
Additional paid-in capital 748,660     742,085       726,679    
Accumulated deficit (747,933)     (684,745)       (566,232)    
Accumulated other comprehensive loss (25)     (260)       (1,672)    
Total stockholders' equity 707 $ 11,598 $ 29,803 57,085 $ 85,642 $ 108,932 $ 136,598 158,779 $ 227,522 $ 249,001
Total liabilities and stockholders' equity $ 51,329     $ 125,844       $ 182,237